What Are the Short-Term Effects of Vaping?

Within minutes of inhaling e-cigarette aerosol, your heart rate and blood pressure climb, your arteries stiffen, and the protective mucus-clearing system in your airways slows down. These changes are measurable and well documented across dozens of studies, and most reverse within hours once you stop. But the fact that they reverse quickly does not mean they are harmless, especially if you vape repeatedly throughout the day. The short-term picture is more complex than either the “it’s just water vapor” dismissal or the “it’s as bad as smoking” alarm suggests.

What Happens to Your Heart and Blood Vessels

The cardiovascular effects of a single vaping session are surprisingly pronounced. A 2025 meta-analysis pooling data from multiple acute-exposure studies found that e-cigarette use raised heart rate by about 11 beats per minute and boosted systolic blood pressure by roughly 13 points and diastolic by about 8 points compared to non-use.¹ These spikes are driven primarily by nicotine, which stimulates the sympathetic nervous system the same way it does when delivered by a conventional cigarette.

Beyond the numbers on a blood pressure cuff, vaping also affects how your blood vessels behave at a structural level. A controlled study in healthy smokers found that a single e-cigarette session reduced flow-mediated dilation (a measure of how well arteries relax), increased arterial stiffness, and impaired blood flow to the skin.² In plain terms, arteries that should be supple and responsive temporarily become stiffer and less efficient at delivering blood. These vascular changes matter because, over time, repeated episodes of stiffening and endothelial dysfunction are the same processes that set the stage for atherosclerosis and cardiovascular disease.

A broader systematic review across multiple body systems confirmed that e-cigarettes, regardless of whether they contain nicotine, induce oxidative stress, inflammation, and increased vascular stiffness.³ That “regardless of nicotine” part is worth pausing on. It means the propylene glycol, vegetable glycerin, flavorings, and thermal degradation products in the aerosol are causing vascular harm independently of nicotine’s well-known stimulant effects.

How Your Airways Respond

Your respiratory tract has a built-in cleaning system. Tiny hair-like projections called cilia beat in coordinated waves, pushing a thin layer of mucus (and whatever it has trapped) up and out. This process, called mucociliary clearance, is one of the lungs’ primary defenses against inhaled particles and pathogens. Vaping disrupts it.

A study comparing e-cigarette users to nonsmokers measured how long it took for the nasal mucosa to clear a test substance. Vapers took an average of about 14 seconds compared to roughly 11 seconds for non-users, a statistically significant delay indicating that the clearance system was working less efficiently.⁴ That may sound like a small margin, but mucociliary clearance operates continuously, and even modest slowing can accumulate into meaningfully reduced protection against infection and irritants.

Research into the mechanism behind this slowdown points directly to nicotine in the aerosol. Nicotine reduces the activity of a key ion channel (CFTR) and disrupts the thin liquid layer that sits on top of airway cells and keeps the cilia hydrated and mobile. The result is delayed clearance and a drier, less effective airway surface.⁵ One acute-challenge study found that e-cigarette use actually sped up mucus clearance in the peripheral lung in the short term, which sounds like a good thing but likely reflects an irritant response: the lungs accelerating clearance as an emergency reaction to something they recognize as harmful.⁶

A cross-sectional study of young adults found that e-cigarette users had lower forced expiratory volume (the amount of air you can blow out in one second) compared to non-users. Dual users, those who both vaped and smoked, showed the worst results.⁷ This finding matters because many people who vape also smoke conventional cigarettes, and combining the two appears to compound the respiratory harm rather than offset it.

What You Are Actually Inhaling

The aerosol produced by an e-cigarette is not steam. When propylene glycol and vegetable glycerin are heated by the coil, they break down into smaller molecules, some of which are known toxicants. A study of adolescent e-cigarette users found significantly higher urinary levels of metabolites of acrolein, acrylonitrile, propylene oxide, acrylamide, and crotonaldehyde compared to non-users.⁸ These chemicals are known irritants and, in some cases, carcinogens when exposure is sustained. Their presence in the urine of vapers confirms that the body is absorbing them, not just passing them through the lungs.

Cannabis vaping introduces additional chemistry. Terpenes, the aromatic compounds in cannabis concentrates, decompose when heated, and the breakdown products can make up a substantial fraction of the aerosol gas phase. Research has shown that the levels of these degradation products rise sharply with the power applied to the device, meaning higher wattage settings create more of them.⁹ This is one reason why device settings and the composition of the liquid matter so much to the risk profile of any given vaping session.

How does the cellular-level damage compare to cigarette smoke? A transcriptomic study comparing the two found that cigarette smoke triggered massive gene changes in bronchial cells, particularly in pathways related to oxidative stress and cell death, while e-cigarette vapor caused much more modest gene-level disruption.¹⁰ That is genuinely reassuring for people who have switched from smoking to vaping. But “less gene disruption than cigarettes” is not the same as “no gene disruption,” and it says nothing about whether that lower level of disruption is safe over years of daily exposure.

Why Flavor Choice Changes the Risk

Not all e-liquids are equally harmful. The flavoring chemicals added to create tastes like menthol, cinnamon, and strawberry are often compounds considered safe for ingestion in food but never tested for safety when heated and inhaled repeatedly. The distinction matters because the lungs are far more sensitive than the digestive tract.

In cell-culture experiments, menthol flavoring stood out as the most toxic option tested, killing about 45% of lung epithelial cells after just two hours at a low concentration. By 48 hours, more than 80% of cells were dead even at the lowest concentration tested.¹¹ A systematic review across multiple studies confirmed that cinnamon, strawberry, and menthol flavors consistently showed more harmful effects than other flavors, primarily through increased inflammation and greater cell death.¹²

There is also a flavor-category pattern. E-liquids with dessert, fruit, and candy flavors produced more oxidative stress than tobacco-flavored liquids in lab testing. And cinnamon-roll-flavored liquid specifically triggered a significant inflammatory response in lung cells, while tobacco and grape flavors did not.¹³ The practical takeaway is that the specific liquid you choose can shift your short-term risk considerably. Someone vaping an unflavored or tobacco-flavored liquid may be exposing their lungs to significantly less acute irritation than someone vaping a menthol or cinnamon product.

EVALI and the Vitamin E Acetate Problem

In 2019, a cluster of severe lung injuries linked to vaping made international news. The condition was named EVALI (e-cigarette or vaping product use-associated lung injury), and it primarily affected people using THC-containing cartridges purchased from informal or illicit sources. The prime suspect was vitamin E acetate, a thickening agent added to illicit THC oils. It was found in the lung fluid of many affected patients.¹⁴

How does an oily vitamin cause acute lung failure? Research in mice has shown that when vitamin E acetate is inhaled as an aerosol, alveolar macrophages (the immune cells that clean up the lungs) try to break it down but cannot. The result is oxidative stress, cell death, and a flood of inflammatory signals.¹⁵ A separate line of research found that vitamin E acetate also disrupts pulmonary surfactant, the thin film that keeps your lung’s air sacs from collapsing. Increasing concentrations of vitamin E acetate made the surfactant layer softer and more prone to collapse, which helps explain the shortness of breath and pneumonitis seen in EVALI patients.¹⁶

EVALI cases dropped sharply after public health warnings about illicit THC cartridges, and the condition is now relatively rare. But the episode illustrates an important broader point about vaping: the safety of what you inhale depends entirely on what is in the liquid, and not all liquids are created equal. Legitimate nicotine e-liquids from regulated manufacturers were not implicated in EVALI. The risk came from unregulated, adulterated products.

How Nicotine Salt Formulations Change the Experience

If you have used a modern pod-style device, you have almost certainly encountered nicotine salts. These are formulations where nicotine is combined with an acid (commonly benzoic acid) to lower the pH, which reduces the harsh throat hit that freebase nicotine delivers at high concentrations. The result is that you can inhale much higher nicotine levels comfortably.

A randomized clinical trial confirmed the sensory difference: salt-based formulations scored substantially higher on appeal, sweetness, and smoothness, and substantially lower on bitterness and harshness, compared to freebase formulations.¹⁷ This matters for short-term effects because the smoothness encourages longer puffs and more frequent use, increasing the total nicotine and aerosol exposure per session.

Interestingly, the relationship between formulation and blood nicotine levels is not straightforward. A study in mice found that freebase nicotine actually produced higher serum nicotine levels than salt formulations of the same concentration, and females had higher levels than males within the freebase group.¹⁸ A human study found a similar pattern: conditions with a higher proportion of freebase nicotine produced a greater plasma nicotine boost after a controlled puffing session.¹⁹ So nicotine salts feel smoother and more appealing, but milligram for milligram they may actually deliver less nicotine to your blood than freebase. The catch is that their smoothness often leads users to choose much higher concentrations (50 mg/mL is common in salt pods versus 3 to 6 mg/mL in freebase liquids), which more than compensates for any per-puff difference in absorption.

Dry Mouth, Sore Throat, and Oral Effects

One of the most commonly reported immediate effects of vaping is dry mouth. Propylene glycol is hygroscopic, meaning it pulls moisture out of surrounding tissue, and the heated aerosol itself can dehydrate the oral mucosa on contact. A meta-analysis covering over 6,800 cases found that about a third of e-cigarette users reported dry mouth, compared to about a quarter of combustible tobacco users.²⁰ Persistent dry mouth is more than a comfort issue; saliva is your mouth’s primary defense against tooth decay and gum disease, so chronic dryness can accelerate dental problems.

Sore throat is another frequently cited complaint, particularly among newer users or those using high-nicotine freebase liquids. This generally fades as users adjust or switch to smoother formulations, but it signals genuine irritation of the pharyngeal tissue. In rare cases, vaping can cause more serious thermal injuries. A case report documented a pharyngeal burn caused by device malfunction, where leaking hot liquid or superheated aerosol caused erythema, edema, and blistering in the throat.²¹ Device explosions and burns from malfunctioning batteries represent a separate and distinct category of acute harm, though they are statistically rare.

What Bystanders Breathe

People near someone who is vaping are exposed to exhaled aerosol, and the question of whether that secondhand exposure causes measurable physiological changes has started to receive research attention. One controlled study found that non-vaping subjects exposed to secondhand vapor for 20 minutes had a small but significant increase in oral temperature, though blood sugar and a basic lung function measure (forced vital capacity) were not significantly affected.²² The evidence here is still thin. Secondhand e-cigarette aerosol almost certainly exposes bystanders to some level of fine particles, nicotine, and volatile compounds, but at much lower concentrations than what the vaper inhales. Whether these low-level exposures matter over time is an open question that current research cannot definitively answer.

Nicotine, Attention, and the Brain

The cognitive effects of vaping are, unsurprisingly, largely the cognitive effects of nicotine. A balanced-placebo study (a design that separates the actual drug effect from the expectation of receiving it) found that nicotine delivered by e-cigarette improved sustained attention, with a stronger effect in women. The study also found sex differences in reward and aversion: nicotine was perceived as rewarding by men but aversive by women, while enjoyment of the throat and respiratory sensations was highest in participants who expected nicotine but did not receive it.²³ These findings reinforce that a meaningful part of the vaping experience is psychological. The ritual, the throat hit, and the expectation of a nicotine effect all contribute to the perceived reward, which helps explain why nicotine-free vaping still appeals to some users.

For adolescents and young adults, the short-term cognitive boost from nicotine carries a particular risk. The developing brain is more susceptible to nicotine dependence, and what starts as a subtle improvement in focus can quickly become a cycle where concentration feels impossible without the next hit. Qualitative research with Australian adolescents captured this progression vividly: participants described declining fitness and impaired breathing as their vaping escalated, alongside growing difficulty stopping.²⁴

How Vaping Compares to Not Vaping and to Smoking

The honest framing is that e-cigarettes sit somewhere between clean air and cigarette smoke in terms of short-term harm, but the gap between vaping and clean air is not trivial. At the gene-expression level, cigarette smoke causes far more disruption to bronchial cells than e-cigarette vapor does.¹⁰ That aligns with the general expert consensus that vaping is less acutely harmful than smoking. But the cardiovascular spikes, the airway clearance impairment, the oxidative stress, the immune-cell disruption, and the flavor-dependent toxicity are all real, measurable effects that happen every time you vape.

For someone who has never smoked, the relevant comparison is not “vaping versus cigarettes” but “vaping versus not vaping,” and by that standard, every short-term effect described above is a net negative. For current smokers who switch completely to vaping, the short-term picture is more favorable: the cardiovascular and respiratory burden likely drops, even though it does not disappear. The worst position, as the lung function data on dual users suggest, is doing both.⁷